Pricing Log in Create free account
Saturday 17 October 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insulet Corporation (PODD) Operating margin

Alert me on Operating margin

Insulet Corporation's operating margin over the twelve months to 30 June 2026 was 16.9%, down 0.6 percentage points from fiscal 2025 (17.5%). Over the past ten years it has ranged from −18.5% (fiscal 2015) to 17.5% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −15.0% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 17.5% 2.59
FY2024 14.9% 1.94
FY2023 13.0% 10.09
FY2022 2.88% (8.59)
FY2021 11.5% 5.78
FY2020 5.69% (1.08)
FY2019 6.77% 1.91
FY2018 4.86% 6.46
FY2017 −1.60% 1.32
FY2016 −2.92% 15.55

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 16.2% 0.15
Mar 2026 16.0% (2.63)
Dec 2025 18.7% 2.00
Sep 2025 16.7% (2.00)
42 more quarters

Against its own ten years

Low −18.5% High 17.5%
Ten-year median 5.69%
Current reading's percentile 90

Operating margin against peers

Company Operating margin
GMED Globus Medical, Inc. compare 20.3%
PODD Insulet Corporation 16.9%
PEN Penumbra, Inc. compare 12.5%
HAE Haemonetics Corporation compare 11.9%
BIO.B Bio-Rad Laboratories, Inc. compare 2.05%
BIO Bio-Rad Laboratories, Inc. compare 2.05%
SNN Smith & Nephew SNATS, Inc. compare 0.00%
BRKR Bruker Corporation compare −0.87%
GKOS Glaukos Corporation compare −31.6%
Medical Devices industry median −15.0%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on PODD